ArticleFrontiers in oncology2022

Aptamer-Based Triple Serum Fluorescence Intensity Assay: A Novel and Feasible Method for the Clinical Diagnosis of Primary Hepatic Carcinoma.

Jian-Ming Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.